Larry Ellison Donates $200 Million for Cancer Research

The Oracle cofounder’s gift will fund a new institute at the University of Southern California.

Written byTanya Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Larry EllisonFLICKR, ORACLE PRLarry Ellison, the billionaire cofounder of software giant Oracle, has donated $200 million to the University of Southern California (USC) to fund the creation of a new institute for cancer research, the university announced yesterday (May 11). The Lawrence J. Ellison Institute for Transformative Medicine will be led by USC Professor of Medicine and Engineering David Agus, and will combine diverse fields of research.

“This investment by Larry Ellison in USC is as inspirational as it is momentous, and it will serve as a dynamic force for change in how we approach cancer treatment and prevention,” USC President C. L. Max Nikias said in the statement.

The money will mostly be used to fund a new building in west Los Angeles—set to open in around 2.5 years—and to support research and artist residency programs, Agus told Bloomberg Technology. “There will be clinics, engineering labs, think tanks, and kids will be able to go on tours all day because we need to excite the next generation,” he said.

Ellison, who is worth nearly $50 billion, has previously given money to aging research, animal welfare, and polio eradication efforts, The Wall ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA